AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

11,790.00p
   
  • Change Today:
    -20.00p
  • 52 Week High: 13,276.00p
  • 52 Week Low: 9,667.00p
  • Currency: UK Pounds
  • Shares Issued: 1,550.68m
  • Volume: 1,029,380
  • Market Cap: £182,826m
  • RiskGrade: 123

Regulatory News

Holding(s) in Company 28-Aug-2025 15:00 RNS
Holding(s) in Company 26-Aug-2025 15:00 RNS
Holding(s) in Company 21-Aug-2025 15:00 RNS
Director/PDMR Shareholding 18-Aug-2025 15:00 RNS
Holding(s) in Company 15-Aug-2025 15:00 RNS
Holding(s) in Company 12-Aug-2025 15:00 RNS
Total Voting Rights 01-Aug-2025 15:00 RNS
H1 and Q2 2025 results 29-Jul-2025 07:00 RNS
Gefurulimab nanobody met Phase III endpoints 24-Jul-2025 07:00 RNS
AstraZeneca plans to invest $50bn in the US 22-Jul-2025 07:00 RNS
Update on anselamimab in AL amyloidosis 16-Jul-2025 07:00 RNS
Baxdrostat met primary endpt in BaxHTN PhIII trial 14-Jul-2025 07:00 RNS
Imfinzi approved in the EU for bladder cancer 04-Jul-2025 07:00 RNS
Total Voting Rights 01-Jul-2025 15:00 RNS
Datroway approved in US for EGFRm lung cancer 24-Jun-2025 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 11,790.00p
Change Today -20.00p
% Change -0.17 %
52 Week High 13,276.00p
52 Week Low 9,667.00p
Volume 1,029,380
Shares Issued 1,550.68m
Market Cap £182,826m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 4
Sell 0
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 07-Aug-25 20-Feb-25
Paid 08-Sep-25 24-Mar-25
Amount 103.00¢ 210.00¢

Trades for 29-Aug-2025

Time Volume / Share Price
15:23 0 @ 11,802.00p
15:12 0 @ 11,824.00p
16:47 879 @ 11,790.00p
16:47 5,010 @ 11,819.84p
16:36 98 @ 11,790.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page